ParaGen Technologies develops synthetic nanofiber scaffolds that replicate the extracellular matrix to enhance cell adhesion and proliferation, facilitating tissue regeneration in clinical areas such as wound care, orthopedics, vascular, and hernia repair. The company addresses the limitations of existing synthetic and biologic implants, which often lead to rejection and inadequate integration within the body.
Funding
$14.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ICMCFounders
Product
Problem
Existing synthetic and biologic implants often face limitations such as rejection by the body and inadequate tissue integration. These issues hinder effective tissue regeneration and can lead to complications in wound care, orthopedic procedures, vascular repair, and hernia treatment.
Solution
ParaGen Technologies develops synthetic nanofiber scaffolds designed to mimic the natural extracellular matrix, promoting enhanced cell adhesion and proliferation for improved tissue regeneration. These scaffolds aim to overcome the drawbacks of current implants by providing an environment that encourages seamless integration with the body's tissues, reducing the risk of rejection and encapsulation. By tailoring this nanofiber technology to specific clinical areas, ParaGen Technologies is creating specialized medical devices for wound care, orthopedics, vascular applications, and hernia repair. The company's approach focuses on achieving excellent biointegration, consistency, and high-function regrowth without the issues associated with traditional synthetic or biologic solutions.
Target Audience
The primary target audience includes medical device companies and healthcare providers specializing in wound care, orthopedics, vascular surgery, and hernia repair.
Features
- Synthetic nanofiber scaffolds that replicate the structure of the extracellular matrix
- Enhanced cell adhesion and proliferation for effective tissue regeneration
- Minimized risk of rejection or encapsulation compared to existing implants
- Customizable scaffold designs tailored for wound care, orthopedics, vascular, and hernia repair applications
- ISO-certified quality management system ensuring consistent product quality
- Portfolio of 38 issued and pending patents related to nanofiber scaffold technology